# YUM Brands Inc: overview

YUM · NYSE · CIK 1041061 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/yum.md) · [Financials](/companies/yum/financials.md) · [Filings](/companies/yum/filings.md) · [Insiders](/companies/yum/insiders.md)

Latest reported revenue: [$2.17bn](/filings/0001041061-26-000160.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:Revenues, accession 0001041061-26-000160).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,826](/filings/0001041061-25-000109.md) | [2,362 d](/filings/0001041061-26-000084.md) | [1,787](/filings/0001041061-26-000119.md) | [1,933](/filings/0001041061-26-000160.md) | [1,979](/filings/0001041061-25-000109.md) | [2,515 d](/filings/0001041061-26-000084.md) | [2,059](/filings/0001041061-26-000119.md) | [2,169](/filings/0001041061-26-000160.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [33.9%](/filings/0001041061-25-000109.md) | [27.8% d](/filings/0001041061-26-000084.md) | [30.7%](/filings/0001041061-26-000119.md) | [32.2%](/filings/0001041061-26-000160.md) | [33.7%](/filings/0001041061-25-000109.md) | [29.3% d](/filings/0001041061-26-000084.md) | [31.3%](/filings/0001041061-26-000119.md) | [30.2%](/filings/0001041061-26-000160.md) |
| Net margin | % | [20.9%](/filings/0001041061-25-000109.md) | [17.9% d](/filings/0001041061-26-000084.md) | [14.2%](/filings/0001041061-26-000119.md) | [19.3%](/filings/0001041061-26-000160.md) | [20.1%](/filings/0001041061-25-000109.md) | [21.3% d](/filings/0001041061-26-000084.md) | [21.0%](/filings/0001041061-26-000119.md) | [39.3%](/filings/0001041061-26-000160.md) |
| Diluted EPS | $ per share | [1.35](/filings/0001041061-25-000109.md) | not reported | [0.90](/filings/0001041061-26-000119.md) | [1.33](/filings/0001041061-26-000160.md) | [1.41](/filings/0001041061-25-000109.md) | not reported | [1.55](/filings/0001041061-26-000119.md) | [3.08](/filings/0001041061-26-000160.md) |
| Free cash flow | $m | [419 d](/filings/0001041061-25-000109.md) | [407 d](/filings/0001041061-26-000084.md) | [333](/filings/0001041061-26-000119.md) | [375 d](/filings/0001041061-26-000160.md) | [449 d](/filings/0001041061-25-000109.md) | [482 d](/filings/0001041061-26-000084.md) | [341](/filings/0001041061-26-000119.md) | [407 d](/filings/0001041061-26-000160.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,584](/filings/0001041061-24-000011.md) | [6,842](/filings/0001041061-25-000013.md) | [7,076](/filings/0001041061-26-000084.md) | [7,549](/filings/0001041061-26-000084.md) | [8,214](/filings/0001041061-26-000084.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [32.5%](/filings/0001041061-24-000011.md) | [32.0%](/filings/0001041061-25-000013.md) | [32.8%](/filings/0001041061-26-000084.md) | [31.8%](/filings/0001041061-26-000084.md) | [31.3%](/filings/0001041061-26-000084.md) |
| Net margin | % | [23.9%](/filings/0001041061-24-000011.md) | [19.4%](/filings/0001041061-25-000013.md) | [22.6%](/filings/0001041061-26-000084.md) | [19.7%](/filings/0001041061-26-000084.md) | [19.0%](/filings/0001041061-26-000084.md) |
| Diluted EPS | $ per share | [5.21](/filings/0001041061-24-000011.md) | [4.57](/filings/0001041061-25-000013.md) | [5.59](/filings/0001041061-26-000084.md) | [5.22](/filings/0001041061-26-000084.md) | [5.55](/filings/0001041061-26-000084.md) |
| Free cash flow | $m | [1,476](/filings/0001041061-24-000011.md) | [1,148](/filings/0001041061-25-000013.md) | [1,318](/filings/0001041061-26-000084.md) | [1,432](/filings/0001041061-26-000084.md) | [1,639](/filings/0001041061-26-000084.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/yum/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $4.19bn | 26,190,487 |  | Reduced −245,742 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $3.17bn | 20,017,649 |  | Added +646,740 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.88bn | 18,000,462 |  | Reduced −2,464 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $2.71bn | 16,961,198 |  | Added +135,269 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $2.24bn | 13,996,754 |  | Added +60,698 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.11bn | 13,185,799 |  | Added +200,846 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.35bn | 8,371,753 |  | Added +43,384 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $802.8m | 5,022,027 |  | New +5,022,027 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $774.7m | 4,846,026 |  | Added +809,800 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $740.5m | 4,631,940 |  | Added +4,317,526 |

## Recent filings

[All 1,960 filings](/companies/yum/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-01 | 16:39 ET | [8-K](/filings/0001041061-26-000187.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001041061-26-000187 |
| 2026-08-28 | 12:52 ET | [8-K/A](/filings/0001041061-26-000180.md) | 5.02 Departure or appointment of officers or directors | 0001041061-26-000180 |
| 2026-08-21 | 10:19 ET | [8-K](/filings/0001041061-26-000171.md) | 5.02 Departure or appointment of officers or directors | 0001041061-26-000171 |
| 2026-08-07 | 16:03 ET | [8-K/A](/filings/0001041061-26-000165.md) | 5.02 Departure or appointment of officers or directors | 0001041061-26-000165 |
| 2026-08-07 | 06:15 ET | [8-K](/filings/0001104659-26-092305.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-092305 |
| 2026-08-05 | 18:32 ET | [10-Q](/filings/0001041061-26-000160.md) | Quarterly report, period 2026-06-30 | 0001041061-26-000160 |
| 2026-07-30 | 07:01 ET | [8-K](/filings/0001041061-26-000149.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001041061-26-000149 |
| 2026-06-16 | 17:16 ET | [8-K](/filings/0001193125-26-272881.md) | 1.01 Entry into a material agreement; 8.01 Other events | 0001193125-26-272881 |
| 2026-06-16 | 09:01 ET | [8-K](/filings/0001193125-26-271893.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-271893 |
| 2026-06-02 | 16:33 ET | [8-K](/filings/0001041061-26-000136.md) | 5.02 Departure or appointment of officers or directors | 0001041061-26-000136 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001041061-26-000084.md), filed Feb 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ecbbe7f1-8d6b-4d5d-ae15-efc245179166)

## About the filer

- CIK: 1041061
- Tickers: YUM
- Exchange: NYSE
- SIC code: 5812 Retail-Eating  Places
- State of incorporation: NC
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 15:39 ET. No prices; not investment advice.